ApprovalTrail

Approval · Notice of Compliance 2787 · 1998

SCHEINPHARM CEFACLOR: Notice of Compliance 2787

Issued April 6, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2787
Date
April 6, 1998
Company
Schein Pharmaceutical Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Antibiotic
Canadian reference product
CECLOR (Eli Lilly And Company)

Products in this notice

BrandDINStatus today
SCHEINPHARM CEFACLOR02237729Cancelled Post Market
SCHEINPHARM CEFACLOR02237730Cancelled Post Market

Medicinal ingredients